Zepbound (Tirzepatide)

Zepbound (Tirzepatide)

Purpose

Zepbound is a prescription medication containing the active ingredient tirzepatide. It is primarily indicated for weight management in individuals with obesity (BMI ≥30) or overweight (BMI ≥27 with related conditions such as hypertension or pre-diabetes). This drug is classified as an incretin mimetic, helping to regulate appetite and improve metabolic function.

How It Works

Zepbound works through a dual-action mechanism by targeting both the GLP-1 and GIP receptors. These receptors mimic gut hormones responsible for controlling blood sugar and feelings of satiety. The main actions include:

• Reducing hunger to help control calorie intake.
• Improving insulin sensitivity to enhance blood sugar regulation.
• Slowing stomach emptying to prolong the feeling of fullness.
• Regulating glucose levels, which helps to reduce the risk of hyperglycemia.

Usage

• Administration: Zepbound is administered as a weekly injectable pen for subcutaneous injection.
• Effectiveness: Clinical studies report a weight loss of up to 22.5% of total body weight at the highest dose (15 mg). Best results are observed when combined with dietary modifications and increased physical activity.

Side Effects

Common side effects during the initial adjustment phase may include:

• Nausea
• Vomiting
• Diarrhea
• Constipation

These effects are generally mild and temporary. To mitigate them, ensure adequate hydration and make appropriate dietary adjustments.

Available Dosages

Zepbound is available in six dosage strengths:

• 2.5 mg
• 5 mg
• 7.5 mg
• 10 mg
• 12.5 mg
• 15 mg

Treatment begins with the lowest dose and is gradually increased based on individual tolerance and clinical response.